Related Experiment Video
Updated: Jun 11, 2026
08:14
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
Published on: May 4, 2017
Optimizing on-demand treatment with NovoSeven room temperature stable
1Haemophilia Comprehensive Care Centre, Edouard Herriot University Hospital, Lyon, France. claude.negrier@chu-lyon.fr
Summary
New room temperature stable recombinant activated factor VII (rFVIIa) formulation improves haemophilia treatment. Early initiation of this therapy offers faster bleed resolution, reduced re-bleeding, and enhanced patient convenience.
Area of Science:
- Haematology
- Pharmacology
Background:
- Haemophilia treatment has advanced, improving patient life expectancy.
- Recombinant activated factor VII (rFVIIa) has significantly improved care for haemophilia patients with inhibitors.
- Early treatment initiation with rFVIIa demonstrates enhanced haemostatic efficacy.
Purpose of the Study:
- To evaluate the benefits of a new room temperature stable formulation of NovoSeven (rFVIIa).
- To assess the impact of this formulation on optimizing on-demand treatment for haemorrhagic episodes in haemophilia patients.
Main Methods:
- The study focuses on the clinical and economic advantages of the room temperature stable rFVIIa formulation.
- The evaluation considers factors like early initiation of therapy, bleed resolution, re-bleeding frequency, and product consumption.
Main Results:
- The room temperature stable formulation facilitates early initiation of therapy, leading to faster bleed resolution.
- It reduces the frequency of re-bleeding and decreases overall product consumption.
- Benefits are particularly significant for inhibitor patients, potentially improving musculoskeletal status and reducing disability.
Conclusions:
- The room temperature stable NovoSeven formulation enhances on-demand treatment for haemophilia.
- It offers improved patient quality of life, societal integration, and economic benefits.
- This formulation represents a valuable advancement in haemophilia care, improving compliance and convenience.
Related Concept Videos
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:22Methods of reducing fever
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...